Eli Lilly reserves $470M for new manufacturing plant — and North Carolina is more than pleased

Eli Lilly is adding an eighth site to its network of manufacturing plants in the US, investing $470 million to begin production of injectable products and delivery devices at Research Triangle Park, North Carolina.